The O’Neill Institute for National and Global Health Law at Georgetown University Law Center (O’Neill Institute), the National Viral Hepatitis Roundtable (NVHR), and the Center for Health Law and Policy Innovation (CHLPI) at Harvard Law School have launched a partnership to study viral hepatitis elimination efforts across the United States. The U.S. is facing rising rates of viral hepatitis – despite the availability of vaccines for hepatitis A and B, and a cure for hepatitis C – and reports show that the country is not on track to meet the World Health Organization’s goal of eliminating viral hepatitis by 2030.
Many states have or are developing comprehensive, systemic strategies to improve their capacity to prevent, diagnose, and provide linkage to care for viral hepatitis. Yet no grading system exists to date to assess states’ policy and programmatic capacity to eliminate viral hepatitis.
Hep ElimiNATION: A National Evaluation of States’ Capacity for Viral Hepatitis Elimination will assess the policy landscape and programmatic strategies impacting viral hepatitis elimination in the 50 states, Washington, DC, and Puerto Rico, and offer guidance for states’ ongoing efforts to develop viral hepatitis elimination strategies. Hep ElimiNATION will also release an accompanying Viral Hepatitis Elimination Toolkit that outlines the components of a comprehensive viral hepatitis elimination program and provides guidance and resources to enable jurisdictions to develop actionable elimination strategies.
To learn more about the project visit http://www.eliminatehep.org.
This project is supported by Gilead Sciences. O’Neill, NVHR and CHLPI retain final editorial control over all content.